Premier Perspectives The blog for insider insights in clinical development Medical and Regulatory Affairs FDA’s LDT Proposal and Its Impact on Clinical and Regulatory Professionals By Charles Chrisawn March 6, 2024 Featured Posts Consulting Getting the Support You Need at Every Step of the CE Marking Process By Michael Edwards March 5, 2024 Clinical ResearchPhase 1 - Phase 4 5 Stages of Medical Device Development By Premier Research March 1, 2024 Premier Voices Podcast Conversations with Premier's subject matter experts PREMIER VOICES #15 Enhancing Clinical Trial Accessibility – Bringing Oncology Trials to Patients PREMIER VOICES #13 Early-Phase Oncology – Emerging From the Crisis & Innovating for the Future PREMIER VOICES #12 Direct-to-Patient – Is This the ‘New Normal’ for Clinical Trials? PREMIER VOICES #11 Statistical Considerations in the Wake of COVID-19 PREMIER VOICES #10 COVID-19 Update – How the FDA's Emergency Use Authorization Can Help Develop Therapies Faster Premier Voices #8 Engaging Patients in Clinical Trials w/ Alan Thomas Premier Voices #7 Rare Disease Advocacy & International Ataxia Day w/ Alan Thomas (Ataxia & Me) Premier Voices #6 Operationalizing the New MDR With Janet Kube (Part 2) Premier Voices #5 Operationalizing the New MDR With Janet Kube (Part 1) Premier Voices #4 The Placebo Problem Part 2 With Michael Kuss Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers Blog By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Why Rare Disease Day Matters to Us By Premier Research February 29, 2024 Clinical ResearchPhase 1 - Phase 4 Deviating from the Conventional: Decentralizing Pediatric Rare Disease Clinical Research By Adam Bloomfield February 19, 2024 Clinical ResearchPhase 1 - Phase 4 Advancing Health Outcomes for All: Addressing Diversity and Ethnicity Data Challenges in Global Clinical Research By Stacy Weil February 7, 2024 A World Cancer Day Message from the People of Premier By Premier Research February 2, 2024 Consulting The Economics of Investigational Device Exemption (IDE) Studies: What You Need to Know About Medicare Coverage By Charles Chrisawn January 29, 2024 Consulting Conducting Clinical Studies Under an Investigational Device Exemption By Charles Chrisawn January 29, 2024 1 2 3 … 55 Next × ALSO OF INTEREST7 Questions About Clinical Evaluations for MDRNostalgia or Shell Shock? Assessing PTSD Is a...Designing Pediatric Analgesic Treatment...